Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases

Details for Australian Patent Application No. 2007313639 (hide)

Owner MGP Biotechnologies, Inc.

Inventors Acey, Roger A.; Nakayama, Kensaku

Agent Pizzeys

Pub. Number AU-A-2007313639

PCT Pub. Number WO2008/055249

Priority 60/863,764 31.10.06 US

Filing date 31 October 2007

Wipo publication date 8 May 2008

International Classifications

C07F 9/12 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 31/664 (2006.01) - Amides of phosphorus acids

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07F 9/24 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/40 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/46 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/055249 Priority application(s): WO2008/055249

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313659-Method and apparatus for downloading ancillary program data to a DVR

2007313638-An implantable fluid management device for the removal of excess fluid